Saint Louis University

FDA regulations require that any subsequent use of the investigational product at the institution have prospective IRB review and approval. FDA acknowledges, however, that it would be inappropriate to deny emergency treatment to a second individual if the only obstacle is that the IRB has not had sufficient time to convene a meeting to review the issue.

 

Test Article*

Adefovir Dipivoxil

ALIMTA® (pemetrexed)

All-Trans Retinoic Acid (ATRA) IV (Liposomal-Tretinoin)

Amiodarone I.V.

Amphotericin B Lipid Complex (ABLC)

AR623-41 (Liposomal Retinoic Acid)

Ceprate TCD System

Compound 506U78

Defibrotide

Extracorporeal Porcine Hepatocyte Perfusion

I.V. Sodium Benzoate and Sodium Pheylbutyrate

Inhaled Nitric Oxide

Linezolid

m-(131I)  Iodobenzylguanadine

Mylotarg

Nitric Oxide

Pantethine

Pleconaril

Prochymal

Recombinant Human Activated Protein C

Respiratory Syncytial Virus Immune Globulin Intravenous

Sofosbuvir

Sygen

Synercid

Temodal

Tertrahydrobiopterin

Thalidomide

Thymosin- -1

TPI 287

Voraxaze

VSD Closure Device by AGA

 

*Please note: Test articles are listed by the name reported to the IRB. Please look for a product by known trade names, generic names, or common mis-spellings.